Search research articles
Contact Us
Filters
Showing results (1-10 of 121) with videos related to
Page
of 13
Sort By:
International Journal of Clinical Pharmacology and Therapeutics
|
December 24, 2011
Adaptive randomization procedures for the web-based randomization system RANDI2
Daniel Schrimpf, Lothar R Pilz
International Journal of Clinical Pharmacology and Therapeutics
|
December 25, 2012
Design of clinical studies: adaptive randomization and progression-free survival (PFS) as an endpoint in clinical studies of advanced non-small cell lung cancer (NSCLC)
Daniel Schrimpf, Christian Manegold, Lothar R Pilz
Human Pathology
|
October 19, 2015
Synchronous pituitary adenoma and pituicytoma
Marian C Neidert, Henning Leske, Jan-Karl Burkhardt, et al.
Journal of Neuropathology and Experimental Neurology
|
February 28, 2016
Malignant Transformation of a Dysembryoplastic Neuroepithelial Tumor (DNET) Characterized by Genome-Wide Methylation Analysis
Dieter Henrik Heiland, Ori Staszewski, Martin Hirsch, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 8, 2018
Integrated analysis of dynamic FET PET/CT parameters, histology, and methylation profiling of 44 gliomas
Manuel Röhrich, Kristin Huang, Daniel Schrimpf, et al.
Acta Neuropathologica Communications
|
February 22, 2019
Methylation array profiling of adult brain tumours: diagnostic outcomes in a large, single centre
Zane Jaunmuktane, David Capper, David T W Jones, et al.
Acta Neuropathologica Communications
|
January 12, 2023
Comparison of transcriptome profiles between medulloblastoma primary and recurrent tumors uncovers novel variance effects in relapses
Konstantin Okonechnikov, Aniello Federico, Daniel Schrimpf, et al.
Acta Neuropathologica
|
June 7, 2024
Clinically unfavorable transcriptome subtypes of non-WNT/non-SHH medulloblastomas are associated with a predominance in proliferating and progenitor-like cell subpopulations
Konstantin Okonechnikov, Daniel Schrimpf, Jan Koster, et al.
Brain Pathology (Zurich, Switzerland)
|
February 25, 2022
Prognostic impact of genetic alterations and methylation classes in meningioma
Anna S Berghoff, Thomas Hielscher, Gerda Ricken, et al.
Acta Neuropathologica
|
March 24, 2018
Molecular characterization of medulloblastomas with extensive nodularity (MBEN)
Andrey Korshunov, Felix Sahm, Damian Stichel, et al.
Page
of 13
Search research articles
Search
Showing results (1-10 of 121) with videos related to
Sort By:
Page
of 13
International Journal of Clinical Pharmacology and Therapeutics
|
December 24, 2011
Adaptive randomization procedures for the web-based randomization system RANDI2
Daniel Schrimpf, Lothar R Pilz
International Journal of Clinical Pharmacology and Therapeutics
|
December 25, 2012
Design of clinical studies: adaptive randomization and progression-free survival (PFS) as an endpoint in clinical studies of advanced non-small cell lung cancer (NSCLC)
Daniel Schrimpf, Christian Manegold, Lothar R Pilz
Human Pathology
|
October 19, 2015
Synchronous pituitary adenoma and pituicytoma
Marian C Neidert, Henning Leske, Jan-Karl Burkhardt, et al.
Journal of Neuropathology and Experimental Neurology
|
February 28, 2016
Malignant Transformation of a Dysembryoplastic Neuroepithelial Tumor (DNET) Characterized by Genome-Wide Methylation Analysis
Dieter Henrik Heiland, Ori Staszewski, Martin Hirsch, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 8, 2018
Integrated analysis of dynamic FET PET/CT parameters, histology, and methylation profiling of 44 gliomas
Manuel Röhrich, Kristin Huang, Daniel Schrimpf, et al.
Acta Neuropathologica Communications
|
February 22, 2019
Methylation array profiling of adult brain tumours: diagnostic outcomes in a large, single centre
Zane Jaunmuktane, David Capper, David T W Jones, et al.
Acta Neuropathologica Communications
|
January 12, 2023
Comparison of transcriptome profiles between medulloblastoma primary and recurrent tumors uncovers novel variance effects in relapses
Konstantin Okonechnikov, Aniello Federico, Daniel Schrimpf, et al.
Acta Neuropathologica
|
June 7, 2024
Clinically unfavorable transcriptome subtypes of non-WNT/non-SHH medulloblastomas are associated with a predominance in proliferating and progenitor-like cell subpopulations
Konstantin Okonechnikov, Daniel Schrimpf, Jan Koster, et al.
Brain Pathology (Zurich, Switzerland)
|
February 25, 2022
Prognostic impact of genetic alterations and methylation classes in meningioma
Anna S Berghoff, Thomas Hielscher, Gerda Ricken, et al.
Acta Neuropathologica
|
March 24, 2018
Molecular characterization of medulloblastomas with extensive nodularity (MBEN)
Andrey Korshunov, Felix Sahm, Damian Stichel, et al.
Page
of 13